NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-...

por Kashfi, Khosrow, Chattopadhyay, Mitali, Kodela, Ravinder
Publicado 2015

Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐ and H(2)S‐releasing hybrid

por Chattopadhyay, Mitali, Kodela, Ravinder, Duvalsaint, Pascale L., Kashfi, Khosrow
Publicado 2016

Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling()

por Vannini, Federica, Chattopadhyay, Mitali, Kodela, Ravinder, Rao, Praveen P.N., Kashfi, Khosrow
Publicado 2015

Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo

por Nath, Niharika, Chattopadhyay, Mitali, Rodes, Deborah B., Nazarenko, Anna, Kodela, Ravinder, Kashfi, Khosrow
Publicado 2015

Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling

por Kodela, Ravinder, Nath, Niharika, Chattopadhyay, Mitali, Nesbitt, Diandra E, Velázquez-Martínez, Carlos A, Kashfi, Khosrow
Publicado 2015